Tremfya 200 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9MB4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,322
Award facts
- Contract value 100% obligated
- $15,322.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,322.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of TREMFYA 200 mg/2 ml syringes. The contract, which concludes on January 21, 2026, was awarded competitively with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that supplies critical medications and medical commodities to federal agencies, particularly the Department of Defense and Veterans Affairs. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitive procurement processes. TREMFYA (guselkumab) is a prescribed biologic medication used in the treatment of certain dermatological and systemic conditions, and this order ensures adequate supply availability for military treatment facilities and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9MB4?
SPE2DR26F9MB4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9MB4 worth?
The government has obligated $15,322 on SPE2DR26F9MB4.
Is contract SPE2DR26F9MB4 an order under another contract?
Yes. SPE2DR26F9MB4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MB4 competed?
The extent of competition for SPE2DR26F9MB4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award